ExitPortfolio company Anokion ceased operations (out of business exit).AnokionAnokionVersant Venturespitchbook.comDEC 6, 2025DEC 6, 2025
InvestmentCo-led $65M Series A for Dualitas Therapeutics to advance bispecific antibodies for immune and inflammatory disease.Dualitas TherapeuticsDualitas TherapeuticsVersant Ventures